EDIT vs TSN · rev $32.3M vs P/E 22, rev $54.44B
Editas Medicine Inc (EDIT) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Tyson Foods Inc (TSN) is a farm products company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. Revenue was up 2.1% from 2024-09-28 to 2025-09-27. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
EDIT currently screens at market cap $375.2M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the EDIT and TSN stock pages for the full models.
Not investment advice.